Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cardiology Advisor
Continued collaboration across disciplines, enhanced focus on standardization, and investments in emerging technologies are imperative for bridging the gaps and driving innovation.
Cardiology February 10th 2026
Conexiant
Beta-blocker use was not associated with reductions in all-cause mortality or cardiovascular mortality compared with the absence of beta-blocker therapy.
Medical News Today (MNT)
Loss of PRDM16 in adipocytes leads to increased sensitivity to ANGII and vascular fibrosis resulting in elevated blood pressure.
Cardiology January 26th 2026
News Medical
Melatonin supplements are widely thought of as a safe and ‘natural’ option to support better sleep, so it was striking to see such consistent and significant increases in serious health outcomes, even after balancing for many other risk factors.
Cardiology November 11th 2025
HFpEF and HFmrEF collectively account for up to 75% of all heart failure cases, yet clinical research and treatment evidence in HFpEF and HFmrEF is substantially limited compared with other types of heart failure.
Cardiology November 4th 2025
HF was independently associated with a 30% to 50% higher IS rate in 2007 to 2010, but this association attenuated to only 10% to 15% higher in 2015 to 2018.
Cardiology September 16th 2025